| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Feb 2026 | 3 Feb 2026 |
| Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday February 13 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended December 31 2025. 2. To discuss any other matter with the permission of the Chairperson. Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31, 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2025. Results for quarter ended 31st December 2025 (As Per BSE Announcement Dated on:13.02.2026) | ||
| Board Meeting | 2 Jan 2026 | 2 Jan 2026 |
| Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . January 02, 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company | ||
| Board Meeting | 14 Nov 2025 | 5 Nov 2025 |
| Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2025 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter and half year ended September 30 2025. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30 2025. Results as on 30.09.2025 (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 5 Sep 2025 | 5 Sep 2025 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors at their meeting held today which commenced at 07.00 pm and concluded at 8.00 pm have considered and approved the following: | ||
| Board Meeting | 13 Aug 2025 | 5 Aug 2025 |
| Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 13 2025 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2025. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter ended June 30 2025. Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 05.00 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30, 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2025. (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 5 Aug 2025 | 5 Aug 2025 |
| Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 3.00 P.M. and concluded at 4.30 P.M. inter- alia have considered and approved the following: Appointment of the following individuals as an Additional Director (Non-Executive Independent Director) of the Company and he shall be designated as Independent Director of the Company each for a term of 5 (five) years with effect from August 05, 2025, subject to the approval of shareholders at General Meeting or Postal Ballot of the Company. 1. Mr. Ketan Bhau Songal (DIN: 11228418 ) 2. Mr. Pravin Gadalya Lachake (DIN: 11228417) 3. Mr. Yogesh Hari Ughada (DIN: 11230183) 4. Mrs. Rekha Hemant Wakh - Woman Director (DIN: 11229667) | ||
| Board Meeting | 28 May 2025 | 16 May 2025 |
| Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Monday May 26 2025 inter alia; 1. To consider approve and take on records Audited financial results of the Company for the quarter and the year ended March 31 2025. 2. To discuss any other matter with the permission of the Chairperson. Pursuant to Regulation 29 and 30 of SEBI LODR Regulations, 2015 and in continuation to our update of intimation of board meeting dated 16.05.2025 We would like to inform you that baord meeting which was supposed to be held has been rescheduled to Wednesday , 28.05.2025, due to unforseen circumstances arising from heavy rains and water logging in Mumbai , making difficult for all directors to attend the Meeting (As Per BSE Announcement dated on 26.05.2025) Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 4.00 P.M. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2025. 2. A copy of the statement of audited Financial Results, Cash Flow statement along with Audited Report submitted by the Statutory Auditors of the Company is attached herewith. (As Per BSE Announcement Dated on: 28/05/2025) | ||
| Board Meeting | 20 May 2025 | 21 May 2025 |
| Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, we would like to inform you that the Board of Director in their Meeting held today which was commenced at 05.45 PM and Concluded at 06.15 PM Inter-alia have consider and approved the Following Appointment of Mr. Prathamesh Chalke as Additional Director (Executive Director) and Occupier of All Units of the Company. Further the aforesaid appointment shall be subject to approval of Members at the ensuing General Meeting /Postal Ballot of the Company. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
